Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of BioForm Medical, Inc.
January 06 2010 - 6:24PM
Business Wire
Law Offices of Howard G. Smith announces that it is
investigating potential claims against the board of directors of
BioForm Medical, Inc. (“BioForm Medical” or the “Company”)
(Nasdaq:BFRM) related to the Company’s merger agreement with Merz
Pharma Group ("Merz") – a privately held company based in
Frankfurt, Germany – to acquire BioForm Medical in a cash
transaction valued at approximately $253 million, based on the
Company’s outstanding shares of common stock.
Under the terms of a definitive agreement entered into by the
parties, Merz will acquire all of the outstanding shares of BioForm
Medical for $5.45 per share in cash pursuant to a cash tender offer
followed by a second-step merger. Following completion of the
transaction, BioForm Medical will become a wholly-owned subsidiary
of Merz and will be renamed Merz Aesthetics. The investigation
concerns possible breaches of fiduciary duty and other violations
of law related to approval of the transaction by the BioForm
Medical board of directors.
If you own shares of BioForm Medical, Inc., if you have
information or would like to learn more about these claims, or if
you wish to discuss these matters or have any questions concerning
this announcement or your rights or interests with respect to these
matters, please contact Howard G. Smith, Esquire, of Law Offices of
Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem,
Pennsylvania 19020 by telephone at (215) 638-4847, Toll Free at
(888) 638-4847, or by email to howardsmith@howardsmithlaw.com, or
visit our website at http://www.howardsmithlaw.com.
Bioform Medical (MM) (NASDAQ:BFRM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bioform Medical (MM) (NASDAQ:BFRM)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Bioform Medical (MM) (NASDAQ): 0 recent articles
More Law Offices of Howard G. Smith News Articles